Loading…

Validation of albumin determined in urine with the HemoCue point-of-care analyser

Albumin concentrations persistently between 20 and 200 mg L in first morning spot urine or urine collected overnight, referred to as microalbuminuria, indicate incipient nephropathy in diabetes mellitus. This study validates a new point-of-care device, the HemoCue Urine Albumin analyser, for handlin...

Full description

Saved in:
Bibliographic Details
Published in:Scandinavian journal of clinical and laboratory investigation 2003, Vol.63 (2), p.119-126
Main Author: VON SCHENCK, H.
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c432t-7b4e2f2f04450d3972709b0dabd1f3a8ae6f4afceec49179006c59c03974c79f3
cites cdi_FETCH-LOGICAL-c432t-7b4e2f2f04450d3972709b0dabd1f3a8ae6f4afceec49179006c59c03974c79f3
container_end_page 126
container_issue 2
container_start_page 119
container_title Scandinavian journal of clinical and laboratory investigation
container_volume 63
creator VON SCHENCK, H.
description Albumin concentrations persistently between 20 and 200 mg L in first morning spot urine or urine collected overnight, referred to as microalbuminuria, indicate incipient nephropathy in diabetes mellitus. This study validates a new point-of-care device, the HemoCue Urine Albumin analyser, for handling, accuracy precision and predictive values (PV±) at 20 mg L. Over a period of 2 months, 200 microalbuminuria samples were selected at the Department of Clinical Chemistry according to the results from the Integra 700 instrument (Roche, R) and analysed on the same day using the HemoCue analyser (HemoCue, H) and the Immage instrument (Beckman, B), in all cases closely following the manufacturers' instructions. Only 137 results were within the measuring range of H, 10-150 mg L. Comparisons yielded regression lines H=1.06R-7.2 (r2=0.94), H=1.08B-3.1 (r2=0.94) and R=1.00B+4.3 (r2=0.99). Inter-assay (n=24) CV% at 12 mg L was H=18.2, R=4.2 and B=2.9 and at 65 mg L: H=6.1, R=1.8 and B=2.6. Intra-assay duplicate CV% for H at 21-40 mg L was 13.2, at 41-80 mg L 10.8 and at 81-150 mg L 9.2. Intra-assay repeatability (n=8) CV% at 28 mg L was 7.2-13.8, at 57 mg L 6.4-8.4 and at 105 mg L 4.3-7.1. External quality assurance urine albumin (B) was +5.7% cf. nephelometry and (R) +1.0% cf. turbidimetry (n=6) method-group means. PV± values were (H versus R) 0.98 0.37 and (H versus B) 0.95 0.65. HemoCue is easy to handle. Results below 20 mg L need to be confirmed at the central laboratory to exclude microalbuminuria. Values above 20 mg L can be used to follow microalbuminuria, as precision allows discerning steps of 10 mg L.
doi_str_mv 10.1080/00365510310000178
format article
fullrecord <record><control><sourceid>proquest_infor</sourceid><recordid>TN_cdi_informaworld_taylorfrancis_310_1080_00365510310000178</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73273328</sourcerecordid><originalsourceid>FETCH-LOGICAL-c432t-7b4e2f2f04450d3972709b0dabd1f3a8ae6f4afceec49179006c59c03974c79f3</originalsourceid><addsrcrecordid>eNp9kNGK1DAUhoMo7rj6AN5IbvSuetKkTYveyKC7woII6m05TU-YLGkzJinLvL0ZZmSRhc1NTsj3_yQfY68FvBfQwQcA2TaNACmgLKG7J2wjGqgr3XbtU7Y53lcFkBfsRUq3hZGyU8_Zhah1I9pebtiP3-jdhNmFhQfL0Y_r7BY-UaZYBpp4Oa2xTPzO5R3PO-LXNIftSnwf3JKrYCuDkTgu6A-J4kv2zKJP9Oq8X7JfX7_83F5XN9-vvm0_31RGyTpXelRU29qCUg1Mste1hn6ECcdJWIkdUmsVWkNkVC90D9CapjdQSGV0b-Ule3fq3cfwZ6WUh9klQ97jQmFNg5a1lrLuCihOoIkhpUh22Ec3YzwMAoajx-GBx5J5cy5fx5mm-8RZXAHengFMBr2NuBiX7jmlewXyWPTpxLnFhjjjXYh-GjIefIj_QvKxd3z8L74j9Hl39D3chjUW5emRX_wFWgefEg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73273328</pqid></control><display><type>article</type><title>Validation of albumin determined in urine with the HemoCue point-of-care analyser</title><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>VON SCHENCK, H.</creator><creatorcontrib>VON SCHENCK, H.</creatorcontrib><description>Albumin concentrations persistently between 20 and 200 mg L in first morning spot urine or urine collected overnight, referred to as microalbuminuria, indicate incipient nephropathy in diabetes mellitus. This study validates a new point-of-care device, the HemoCue Urine Albumin analyser, for handling, accuracy precision and predictive values (PV±) at 20 mg L. Over a period of 2 months, 200 microalbuminuria samples were selected at the Department of Clinical Chemistry according to the results from the Integra 700 instrument (Roche, R) and analysed on the same day using the HemoCue analyser (HemoCue, H) and the Immage instrument (Beckman, B), in all cases closely following the manufacturers' instructions. Only 137 results were within the measuring range of H, 10-150 mg L. Comparisons yielded regression lines H=1.06R-7.2 (r2=0.94), H=1.08B-3.1 (r2=0.94) and R=1.00B+4.3 (r2=0.99). Inter-assay (n=24) CV% at 12 mg L was H=18.2, R=4.2 and B=2.9 and at 65 mg L: H=6.1, R=1.8 and B=2.6. Intra-assay duplicate CV% for H at 21-40 mg L was 13.2, at 41-80 mg L 10.8 and at 81-150 mg L 9.2. Intra-assay repeatability (n=8) CV% at 28 mg L was 7.2-13.8, at 57 mg L 6.4-8.4 and at 105 mg L 4.3-7.1. External quality assurance urine albumin (B) was +5.7% cf. nephelometry and (R) +1.0% cf. turbidimetry (n=6) method-group means. PV± values were (H versus R) 0.98 0.37 and (H versus B) 0.95 0.65. HemoCue is easy to handle. Results below 20 mg L need to be confirmed at the central laboratory to exclude microalbuminuria. Values above 20 mg L can be used to follow microalbuminuria, as precision allows discerning steps of 10 mg L.</description><identifier>ISSN: 0036-5513</identifier><identifier>EISSN: 1502-7686</identifier><identifier>DOI: 10.1080/00365510310000178</identifier><identifier>PMID: 12751693</identifier><identifier>CODEN: SJCLAY</identifier><language>eng</language><publisher>Oslo: Informa UK Ltd</publisher><subject>Albumin-discerning steps ; Albuminuria - urine ; Biological and medical sciences ; Chemistry, Clinical - instrumentation ; Chemistry, Clinical - methods ; Chemistry, Clinical - standards ; decision limit ; diabetes mellitus ; Humans ; Investigative techniques, diagnostic techniques (general aspects) ; Medical sciences ; Outpatients ; Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques ; Point-of-Care Systems ; Predictive Value of Tests ; predictive values ; quality assurance ; Quality Assurance, Health Care ; Reproducibility of Results ; urinary albumin ; Urinary system</subject><ispartof>Scandinavian journal of clinical and laboratory investigation, 2003, Vol.63 (2), p.119-126</ispartof><rights>2003 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2003</rights><rights>2003 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c432t-7b4e2f2f04450d3972709b0dabd1f3a8ae6f4afceec49179006c59c03974c79f3</citedby><cites>FETCH-LOGICAL-c432t-7b4e2f2f04450d3972709b0dabd1f3a8ae6f4afceec49179006c59c03974c79f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,4024,27923,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=14794038$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12751693$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>VON SCHENCK, H.</creatorcontrib><title>Validation of albumin determined in urine with the HemoCue point-of-care analyser</title><title>Scandinavian journal of clinical and laboratory investigation</title><addtitle>Scand J Clin Lab Invest</addtitle><description>Albumin concentrations persistently between 20 and 200 mg L in first morning spot urine or urine collected overnight, referred to as microalbuminuria, indicate incipient nephropathy in diabetes mellitus. This study validates a new point-of-care device, the HemoCue Urine Albumin analyser, for handling, accuracy precision and predictive values (PV±) at 20 mg L. Over a period of 2 months, 200 microalbuminuria samples were selected at the Department of Clinical Chemistry according to the results from the Integra 700 instrument (Roche, R) and analysed on the same day using the HemoCue analyser (HemoCue, H) and the Immage instrument (Beckman, B), in all cases closely following the manufacturers' instructions. Only 137 results were within the measuring range of H, 10-150 mg L. Comparisons yielded regression lines H=1.06R-7.2 (r2=0.94), H=1.08B-3.1 (r2=0.94) and R=1.00B+4.3 (r2=0.99). Inter-assay (n=24) CV% at 12 mg L was H=18.2, R=4.2 and B=2.9 and at 65 mg L: H=6.1, R=1.8 and B=2.6. Intra-assay duplicate CV% for H at 21-40 mg L was 13.2, at 41-80 mg L 10.8 and at 81-150 mg L 9.2. Intra-assay repeatability (n=8) CV% at 28 mg L was 7.2-13.8, at 57 mg L 6.4-8.4 and at 105 mg L 4.3-7.1. External quality assurance urine albumin (B) was +5.7% cf. nephelometry and (R) +1.0% cf. turbidimetry (n=6) method-group means. PV± values were (H versus R) 0.98 0.37 and (H versus B) 0.95 0.65. HemoCue is easy to handle. Results below 20 mg L need to be confirmed at the central laboratory to exclude microalbuminuria. Values above 20 mg L can be used to follow microalbuminuria, as precision allows discerning steps of 10 mg L.</description><subject>Albumin-discerning steps</subject><subject>Albuminuria - urine</subject><subject>Biological and medical sciences</subject><subject>Chemistry, Clinical - instrumentation</subject><subject>Chemistry, Clinical - methods</subject><subject>Chemistry, Clinical - standards</subject><subject>decision limit</subject><subject>diabetes mellitus</subject><subject>Humans</subject><subject>Investigative techniques, diagnostic techniques (general aspects)</subject><subject>Medical sciences</subject><subject>Outpatients</subject><subject>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</subject><subject>Point-of-Care Systems</subject><subject>Predictive Value of Tests</subject><subject>predictive values</subject><subject>quality assurance</subject><subject>Quality Assurance, Health Care</subject><subject>Reproducibility of Results</subject><subject>urinary albumin</subject><subject>Urinary system</subject><issn>0036-5513</issn><issn>1502-7686</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><recordid>eNp9kNGK1DAUhoMo7rj6AN5IbvSuetKkTYveyKC7woII6m05TU-YLGkzJinLvL0ZZmSRhc1NTsj3_yQfY68FvBfQwQcA2TaNACmgLKG7J2wjGqgr3XbtU7Y53lcFkBfsRUq3hZGyU8_Zhah1I9pebtiP3-jdhNmFhQfL0Y_r7BY-UaZYBpp4Oa2xTPzO5R3PO-LXNIftSnwf3JKrYCuDkTgu6A-J4kv2zKJP9Oq8X7JfX7_83F5XN9-vvm0_31RGyTpXelRU29qCUg1Mste1hn6ECcdJWIkdUmsVWkNkVC90D9CapjdQSGV0b-Ule3fq3cfwZ6WUh9klQ97jQmFNg5a1lrLuCihOoIkhpUh22Ec3YzwMAoajx-GBx5J5cy5fx5mm-8RZXAHengFMBr2NuBiX7jmlewXyWPTpxLnFhjjjXYh-GjIefIj_QvKxd3z8L74j9Hl39D3chjUW5emRX_wFWgefEg</recordid><startdate>2003</startdate><enddate>2003</enddate><creator>VON SCHENCK, H.</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><general>Scandinavian University Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>2003</creationdate><title>Validation of albumin determined in urine with the HemoCue point-of-care analyser</title><author>VON SCHENCK, H.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c432t-7b4e2f2f04450d3972709b0dabd1f3a8ae6f4afceec49179006c59c03974c79f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Albumin-discerning steps</topic><topic>Albuminuria - urine</topic><topic>Biological and medical sciences</topic><topic>Chemistry, Clinical - instrumentation</topic><topic>Chemistry, Clinical - methods</topic><topic>Chemistry, Clinical - standards</topic><topic>decision limit</topic><topic>diabetes mellitus</topic><topic>Humans</topic><topic>Investigative techniques, diagnostic techniques (general aspects)</topic><topic>Medical sciences</topic><topic>Outpatients</topic><topic>Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques</topic><topic>Point-of-Care Systems</topic><topic>Predictive Value of Tests</topic><topic>predictive values</topic><topic>quality assurance</topic><topic>Quality Assurance, Health Care</topic><topic>Reproducibility of Results</topic><topic>urinary albumin</topic><topic>Urinary system</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>VON SCHENCK, H.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Scandinavian journal of clinical and laboratory investigation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>VON SCHENCK, H.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Validation of albumin determined in urine with the HemoCue point-of-care analyser</atitle><jtitle>Scandinavian journal of clinical and laboratory investigation</jtitle><addtitle>Scand J Clin Lab Invest</addtitle><date>2003</date><risdate>2003</risdate><volume>63</volume><issue>2</issue><spage>119</spage><epage>126</epage><pages>119-126</pages><issn>0036-5513</issn><eissn>1502-7686</eissn><coden>SJCLAY</coden><abstract>Albumin concentrations persistently between 20 and 200 mg L in first morning spot urine or urine collected overnight, referred to as microalbuminuria, indicate incipient nephropathy in diabetes mellitus. This study validates a new point-of-care device, the HemoCue Urine Albumin analyser, for handling, accuracy precision and predictive values (PV±) at 20 mg L. Over a period of 2 months, 200 microalbuminuria samples were selected at the Department of Clinical Chemistry according to the results from the Integra 700 instrument (Roche, R) and analysed on the same day using the HemoCue analyser (HemoCue, H) and the Immage instrument (Beckman, B), in all cases closely following the manufacturers' instructions. Only 137 results were within the measuring range of H, 10-150 mg L. Comparisons yielded regression lines H=1.06R-7.2 (r2=0.94), H=1.08B-3.1 (r2=0.94) and R=1.00B+4.3 (r2=0.99). Inter-assay (n=24) CV% at 12 mg L was H=18.2, R=4.2 and B=2.9 and at 65 mg L: H=6.1, R=1.8 and B=2.6. Intra-assay duplicate CV% for H at 21-40 mg L was 13.2, at 41-80 mg L 10.8 and at 81-150 mg L 9.2. Intra-assay repeatability (n=8) CV% at 28 mg L was 7.2-13.8, at 57 mg L 6.4-8.4 and at 105 mg L 4.3-7.1. External quality assurance urine albumin (B) was +5.7% cf. nephelometry and (R) +1.0% cf. turbidimetry (n=6) method-group means. PV± values were (H versus R) 0.98 0.37 and (H versus B) 0.95 0.65. HemoCue is easy to handle. Results below 20 mg L need to be confirmed at the central laboratory to exclude microalbuminuria. Values above 20 mg L can be used to follow microalbuminuria, as precision allows discerning steps of 10 mg L.</abstract><cop>Oslo</cop><pub>Informa UK Ltd</pub><pmid>12751693</pmid><doi>10.1080/00365510310000178</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0036-5513
ispartof Scandinavian journal of clinical and laboratory investigation, 2003, Vol.63 (2), p.119-126
issn 0036-5513
1502-7686
language eng
recordid cdi_informaworld_taylorfrancis_310_1080_00365510310000178
source Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
subjects Albumin-discerning steps
Albuminuria - urine
Biological and medical sciences
Chemistry, Clinical - instrumentation
Chemistry, Clinical - methods
Chemistry, Clinical - standards
decision limit
diabetes mellitus
Humans
Investigative techniques, diagnostic techniques (general aspects)
Medical sciences
Outpatients
Pathology. Cytology. Biochemistry. Spectrometry. Miscellaneous investigative techniques
Point-of-Care Systems
Predictive Value of Tests
predictive values
quality assurance
Quality Assurance, Health Care
Reproducibility of Results
urinary albumin
Urinary system
title Validation of albumin determined in urine with the HemoCue point-of-care analyser
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T10%3A19%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_infor&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Validation%20of%20albumin%20determined%20in%20urine%20with%20the%20HemoCue%20point-of-care%20analyser&rft.jtitle=Scandinavian%20journal%20of%20clinical%20and%20laboratory%20investigation&rft.au=VON%20SCHENCK,%20H.&rft.date=2003&rft.volume=63&rft.issue=2&rft.spage=119&rft.epage=126&rft.pages=119-126&rft.issn=0036-5513&rft.eissn=1502-7686&rft.coden=SJCLAY&rft_id=info:doi/10.1080/00365510310000178&rft_dat=%3Cproquest_infor%3E73273328%3C/proquest_infor%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c432t-7b4e2f2f04450d3972709b0dabd1f3a8ae6f4afceec49179006c59c03974c79f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=73273328&rft_id=info:pmid/12751693&rfr_iscdi=true